Lantern Pharma Inc. Files 8-K on Security Holder Vote
Ticker: LTRN · Form: 8-K · Filed: Sep 23, 2025 · CIK: 1763950
| Field | Detail |
|---|---|
| Company | Lantern Pharma Inc. (LTRN) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
Lantern Pharma held a shareholder vote on 9/19, filed 8-K on 9/23.
AI Summary
Lantern Pharma Inc. filed an 8-K on September 23, 2025, reporting on a matter submitted to a vote of security holders on September 19, 2025. The filing details the company's corporate information, including its incorporation in Delaware, principal executive offices in Dallas, Texas, and its standard industrial classification as Pharmaceutical Preparations.
Why It Matters
This filing indicates a significant corporate event involving shareholder decisions, which could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial changes or operational risks.
Key Players & Entities
- Lantern Pharma Inc. (company) — Registrant
- September 19, 2025 (date) — Date of earliest event reported
- September 23, 2025 (date) — Date of report
- Dallas, Texas (location) — Principal Executive Offices
FAQ
What specific matter was submitted to a vote of security holders on September 19, 2025?
The filing does not specify the exact matter submitted to a vote of security holders on September 19, 2025, only that such a submission occurred.
When was Lantern Pharma Inc. incorporated?
Lantern Pharma Inc. was incorporated in Delaware.
What is Lantern Pharma Inc.'s primary business classification?
Lantern Pharma Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
What is the address of Lantern Pharma Inc.'s principal executive offices?
The principal executive offices are located at 1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201.
What is the SEC file number for Lantern Pharma Inc.?
The SEC file number for Lantern Pharma Inc. is 001-39318.
Filing Stats: 606 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-09-23 16:45:37
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value LTRN The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 46KB
- 0001493152-25-014652.txt ( ) — 210KB
- ltrn-20250919.xsd (EX-101.SCH) — 3KB
- ltrn-20250919_lab.xml (EX-101.LAB) — 33KB
- ltrn-20250919_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lantern Pharma Inc., A Delaware Corporation Dated: September 23, 2025 By: /s/ David R. Margrave David R. Margrave, Chief Financial Officer 3